The World Health Organization (WHO) identifies Egypt as one of the largest pharmaceutical markets in the Middle East and Africa, supported by 177 operational manufacturing facilities. A Regional Biotechnology AmbitionEgypt’s ambitions extend beyond domestic healthcare. The strategy combines export growth with regional manufacturing partnerships and technology transfer. Egypt’s advantage lies in combining established pharmaceutical manufacturing capacity with internationally recognized regulation and access to two of the world’s fastest-growing healthcare markets. The Next Stage of GrowthMoving from pharmaceutical manufacturing to biotechnology leadership will require continued investment in research and development, advanced facilities, specialized talent and international partnerships.